BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2915240)

  • 1. Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy.
    Matthay KK; Sather HN; Seeger RC; Haase GM; Hammond GD
    J Clin Oncol; 1989 Feb; 7(2):236-44. PubMed ID: 2915240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative treatment of nonmetastatic visible residual neuroblastoma: a Pediatric Oncology Group study.
    Nitschke R; Smith EI; Altshuler G; Altmiller D; Shuster J; Green A; Castleberry R; Hayes FA; Golembe B; Ducos R
    J Clin Oncol; 1991 Jul; 9(7):1181-8. PubMed ID: 2045858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroblastoma.
    Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M
    Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggressive surgical therapy and radiotherapy for patients with high-risk neuroblastoma treated with rapid sequence tandem transplant.
    von Allmen D; Grupp S; Diller L; Marcus K; Ecklund K; Meyer J; Shamberger RC
    J Pediatr Surg; 2005 Jun; 40(6):936-41; discussion 941. PubMed ID: 15991174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study.
    Matthay KK; Perez C; Seeger RC; Brodeur GM; Shimada H; Atkinson JB; Black CT; Gerbing R; Haase GM; Stram DO; Swift P; Lukens JN
    J Clin Oncol; 1998 Apr; 16(4):1256-64. PubMed ID: 9552023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroblastoma: the Joint Center for Radiation Therapy/Dana-Farber Cancer Institute/Children's Hospital experience.
    Rosen EM; Cassady JR; Frantz CN; Kretschmar C; Levey R; Sallan SE
    J Clin Oncol; 1984 Jul; 2(7):719-32. PubMed ID: 6737018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comprehensive protocol for diagnosis and treatment of childhood neuroblastoma--results of 45 cases].
    Tang JY; Pan C; Chen J; Xu M; Chen J; Xue HL; Gu LJ; Dong R; Ye H; Zhou M; Wang YP
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):770-3. PubMed ID: 17229383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: is cure possible in a small subgroup?
    Philip T; Zucker JM; Bernard JL; Lutz P; Bordigoni P; Plouvier E; Robert A; Roché H; Souillet G; Bouffet E
    J Clin Oncol; 1991 Jun; 9(6):1037-44. PubMed ID: 2033417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localized but unresectable neuroblastoma: treatment and outcome of 145 cases. Italian Cooperative Group for Neuroblastoma.
    Garaventa A; De Bernardi B; Pianca C; Donfrancesco A; Cordero di Montezemolo L; Di Tullio MT; Bagnulo S; Mancini A; Carli M; Pession A; Arrighini A; Di Cataldo A; Tamaro P; Iasonni V; Taccone A; Rogers D; Boni L;
    J Clin Oncol; 1993 Sep; 11(9):1770-9. PubMed ID: 8355044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuroblastomas treated at the Gustave-Roussy Institute from 1975 to 1979. 173 cases].
    Hartmann O; Scopinaro M; Tournade MF; Sarrazin D; Lemerle J
    Arch Fr Pediatr; 1983 Jan; 40(1):15-21. PubMed ID: 6860066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of prognostic factors in the Austrian A-NB87 Neuroblastoma Study].
    Ladenstein R; Ambros PF; Urban C; Ambros IM; Fink FM; Zoubek A; Grienberger H; Schmitt K; Kerbl R; Horcher E; Amann G; Höfler G; Heinzl H; Gadner H; Mutz I
    Klin Padiatr; 1996; 208(4):210-20. PubMed ID: 8926686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study.
    Perez CA; Matthay KK; Atkinson JB; Seeger RC; Shimada H; Haase GM; Stram DO; Gerbing RB; Lukens JN
    J Clin Oncol; 2000 Jan; 18(1):18-26. PubMed ID: 10623689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma.
    Castleberry RP; Kun LE; Shuster JJ; Altshuler G; Smith IE; Nitschke R; Wharam M; McWilliams N; Joshi V; Hayes FA
    J Clin Oncol; 1991 May; 9(5):789-95. PubMed ID: 2016621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of efficacy of treatment for 30 children with neuroblastoma].
    Sun XF; Liu DG; Su YS; Lin TY; Chen XQ; He YJ
    Ai Zheng; 2003 Dec; 22(12):1343-5. PubMed ID: 14693065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study.
    Nickerson HJ; Matthay KK; Seeger RC; Brodeur GM; Shimada H; Perez C; Atkinson JB; Selch M; Gerbing RB; Stram DO; Lukens J
    J Clin Oncol; 2000 Feb; 18(3):477-86. PubMed ID: 10653863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excellent local control from radiation therapy for high-risk neuroblastoma.
    Gatcombe HG; Marcus RB; Katzenstein HM; Tighiouart M; Esiashvili N
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1549-54. PubMed ID: 19211198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: a report from the Childrens Cancer Group.
    Matthay KK; Seeger RC; Reynolds CP; Stram DO; O'Leary MC; Harris RE; Selch M; Atkinson JB; Haase GM; Ramsay NK
    J Clin Oncol; 1994 Nov; 12(11):2382-9. PubMed ID: 7964954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
    Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D
    J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete resection is not required in patients with neuroblastoma under 1 year of age.
    Kaneko M; Iwakawa M; Ikebukuro K; Ohkawa H
    J Pediatr Surg; 1998 Nov; 33(11):1690-4. PubMed ID: 9856897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
    Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK
    J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.